The Association of Community Cancer Centers (ACCC) brings together cancer programs and practices united in commitment to advancing delivery and access to high-quality cancer care. ACCC understands the value patients place on receiving treatment in their home communities and supports its members and the entire oncology specialty in prioritizing equity, diversity, and inclusion in quality cancer care delivery and within the oncology workforce.
The U.S. Centers for Disease Control and Prevention defines health equity simply and clearly: Health equity is when everyone has the opportunity to be as healthy as possible.
Health equity is achieved when all individuals have the opportunity to reach their full health potential, and no one is held back from achieving this potential due to social position or other socially determined circumstances.
Across healthcare—and cancer care—we recognize the critical need to advance health equity to lessen and eliminate health disparities is recognized.
ACCC continues to develop resources and tools to better understand and support equity initiatives in cancer prevention and detection, diagnosis and treatment, access to clinical trials, survivorship and end-of-life care. Please continue to check this webpage for new updates on this important work.
An expert panel reviews currently available data on cancer care disparities, discusses the needs of disadvantaged populations, and shares practical solutions and methods for implementing bias training. (April 20, 2021)
Optimal care delivery changes from place to place—what works best for one location and patient population may not be ideal for another. The same applies to cancer research. Understanding the needs of your patient population is critical to trial design and implementation. How can you proactively involve your community in cancer research activities? (January 27, 2021)
Learn more about resources which already exist, successful models for pharmacist integration into oncology research teams, and the unique skills which pharmacists offer the interdisciplinary team. (October 30, 2020)
Learn how to identify key disparities in clinical trial access for patients with multiple myeloma and explore strategies that can help improve access for underserved communities. (October 21, 2020)
Join Nadine J. Barrett as she details strategies to improve clinical trial accrual for racial and ethnic minorities, as well as other at-risk groups. (July 24, 2020)
Learn about the cultural and logistical barriers to end-of-life health equity and discover strategies that programs can implement to both address palliative care earlier in the care continuum and reduce health disparities.
We discuss how the legacy of racism in American healthcare continues to affect today’s research, and share strategies for cancer programs to effectively communicate with underrepresented and marginalized populations.
Discover what steps cancer programs can take to build trust with patients from marginalized and underrepresented groups and ensure a more equitable and accessible healthcare environment.
Learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioritized community engagement.
Learn how a rural health system harnessed its passion and creativity to work around obstacles to clinical trial access and ensure its patients have access to cutting-edge cancer treatments.
Community Oncology Can Close the Gap in Cancer Research
Development of an actionable framework to address cancer care disparities in medically underserved populations in the United States: expert roundtable recommendations
Real-World Lessons from COVID-19: Driving Oncology Care Forward (2021-22)
Community Oncology Can Close the Gap in Cancer Research (2020-21)